Infectious Diseases Clinical Trials Network (IDCTN)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institute of Allergy and Infectious Diseases (NIAID) is establishing a cooperative network called the Infectious Diseases Clinical Trials Network (IDCTN) to facilitate rapid implementation of clinical trials aligned with NIH and NIAID priorities. This network, comprised of Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC), is designed to support clinical evaluation of therapeutics, vaccines, biologics, diagnostics, and devices targeting both emerging and chronic infectious diseases. The initiative aims to provide the infrastructure and organizational framework necessary to conduct timely clinical studies addressing public health needs that cannot be met through traditional grant mechanisms due to urgent timelines. The CTEUs serve as the clinical backbone for executing trials, while the NCC manages the network’s administration, organizes collaborative efforts, and cultivates innovative research ideas by engaging experts and mentoring future clinical investigators. The contract operates under specific authorities granted by sections of the Public Health Service Act and relevant federal regulations, allowing NIAID to forecast and prepare for this opportunity. The network’s efforts support the NIH’s mission to swiftly respond to infectious disease challenges and improve public health outcomes. For further information, the primary contact is Dr. Marina S. Lee, reachable via email or phone.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by supporting a cooperative network to rapidly implement clinical trials that meet NIH and NIAID priorities. The network, comprised of the Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC), supports the evaluation of therapeutics, vaccines, biologics, diagnostics, and devices targeting infectious diseases, including emerging and chronic infections. The initiative gives the NIH the capabilities to conduct clinical trials and studies for public health priorities, where the timelines of a standard, unsolicited grant would not adequately address the needs of the United States population. The CTEUs provide the clinical infrastructure for implementing the clinical trials and studies. The NCC, comprised of leaders from the CTEUs in collaboration with NIAID, provides the administrative and organizational framework of the network, engages with experts in the field to solicit and generate innovative concepts for advancing public health while mentoring the next generation of clinical trialists. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.